Patent Assignment
Reel/Frame 066597/0347
Assignment of Assignor's Interest
Recorded: 2024-02-14
Pages: 24
Assignor
14245563 CANADA INC.
Executed: 2023-11-30
Assignee
ID BIOMEDICAL CORPORATION OF QUEBEC
2323 BOUL DU PARC-TECHNOLOGIQUE, QUÉBEC, G1P 4R8, CANADA
Covered Property
(1)
Preparation of P2X3 Antagonist
Application:
18/683,520 →
Publication:
US 2024/0351992
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 14, 2024
From: VILLENEUVE, KARINE; KRONENTHAL, DAVID
To: BELLUS HEALTH COUGH INC.
Reel/Frame 066458/0587 →
Merger
Feb 14, 2024
From: BELLUS HEALTH COUGH INC.
To: BELLUS HEALTH INC.
Reel/Frame 066596/0782 →
Assignment of Assignor's Interest
Feb 14, 2024
From: BELLUS HEALTH INC.
To: 14245563 CANADA INC.
Reel/Frame 066596/0934 →
Assignment of Assignor's Interest
Feb 14, 2024
From: ID BIOMEDICAL CORPORATION OF QUEBEC
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
Reel/Frame 066597/0394 →
Change of Address
Apr 16, 2025
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
Reel/Frame 071351/0192 →